Autosomal dominant secundum atrial septal defect with various cardiac and noncardiac defects: a new midline disorder

A Mégarbané1, E Stephan, R Kassab

  • 1Unité de Génétique Médicale, Faculté de Médecine, Université Saint-Joseph, Beirut, Lebanon. megarban@dm.net.lb

Insights

A Lebanese family study identified a new autosomal dominant midline disorder affecting the heart and upper body. This condition, characterized by atrial septal defects and other anomalies, shows high penetrance and variable expressivity.

Area of Science:

  • Genetics
  • Cardiology
  • Developmental Biology

Background:

  • Atrial septal defects (ASDs) are common congenital heart anomalies.
  • Genetic factors play a significant role in the etiology of congenital heart disease.
  • Midline developmental disorders can affect multiple organ systems.

Observation:

  • A Lebanese family with 12 affected individuals presented with atrial septal defects (ASDs).
  • Affected individuals exhibited a spectrum of cardiac anomalies, including conduction defects (left axis deviation, right bundle branch block), arrhythmias (atrial fibrillation, Wolff-Parkinson-White syndrome, nodal atrioventricular rhythm), and valve/outflow tract obstructions (aortic stenosis, pulmonic valve stenosis, Lutembacher syndrome, Ebstein disease).
  • Noncardiac abnormalities included hypertelorism, cleft lip, and pectus excavatum, suggesting a broader developmental field defect.

Findings:

  • The observed constellation of cardiac and noncardiac anomalies represents a previously undescribed autosomal dominant midline disorder.
  • The disorder demonstrates nearly full penetrance and variable expressivity, indicating strong genetic influence with diverse phenotypic manifestations.
  • Genetic mapping excluded known loci associated with atrial septal defects or cardiac conduction block, suggesting a novel genetic locus.

Implications:

  • This discovery expands our understanding of the genetic basis of congenital heart disease and midline developmental disorders.
  • Identification of this novel genetic syndrome provides a new avenue for etiological research and potential therapeutic targets.
  • Further investigation into the genetic mutation responsible for this disorder could elucidate fundamental mechanisms of cardiac and craniofacial development.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...